C67.9 - Malignant neoplasm of bladder, unspecified
| ICD-10: | C67.9 |
| Short Description: | Malignant neoplasm of bladder, unspecified |
| Long Description: | Malignant neoplasm of bladder, unspecified |
| Status: | Valid for Submission |
| Version: | ICD-10-CM 2023 |
| Code Classification: |
C67.9 is a billable ICD-10 code used to specify a medical diagnosis of malignant neoplasm of bladder, unspecified. The code is valid during the fiscal year 2023 from October 01, 2022 through September 30, 2023 for the submission of HIPAA-covered transactions.
The following anatomical sites found in the Table of Neoplasms reference this diagnosis code given the correct histological behavior: Neoplasm, neoplastic bladder (urinary) or Neoplasm, neoplastic bladder (urinary) orifice or Neoplasm, neoplastic bladder (urinary) wall .
Unspecified diagnosis codes like C67.9 are acceptable when clinical information is unknown or not available about a particular condition. Although a more specific code is preferable, unspecified codes should be used when such codes most accurately reflect what is known about a patient's condition. Specific diagnosis codes should not be used if not supported by the patient's medical record.
Approximate Synonyms
The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:
- Adenocarcinoma of bladder
- Carcinoma of bladder
- Carcinoma of urinary bladder, invasive
- Carcinoma of urinary bladder, superficial
- Local recurrence of malignant tumor of urinary bladder
- Malignant neoplasm of augmented bladder
- Malignant tumor involving an organ by direct extension from bladder
- Malignant tumor involving an organ by separate metastasis from bladder
- Malignant tumor involving prostate by direct extension from bladder
- Malignant tumor involving prostate by separate metastasis from bladder
- Malignant tumor involving seminal vesicle by direct extension from bladder
- Malignant tumor involving seminal vesicle by separate metastasis from bladder
- Malignant tumor involving ureter by direct extension from bladder
- Malignant tumor involving ureter by separate metastasis from bladder
- Malignant tumor involving urethra by direct extension from bladder
- Malignant tumor involving urethra by separate metastasis from bladder
- Malignant tumor involving uterine corpus by direct extension from bladder
- Malignant tumor involving uterine corpus by separate metastasis from bladder
- Malignant tumor involving vagina by direct extension from bladder
- Malignant tumor involving vagina by separate metastasis from bladder
- Malignant tumor of seminal vesicle
- Malignant tumor of seminal vesicle
- Malignant tumor of urinary bladder
- Metastasis from malignant tumor of bladder
- Obstructive nephropathy due to bladder cancer
- Obstructive nephropathy due to malignancy
- pN1: Metastasis in a single lymph node, 2 cm or less in greatest dimension
- pN2: Metastasis in a single lymph node, more than 2 cm but not more than 5 cm in greatest dimension; or multiple lymph nodes, none more than 5 cm in greatest dimension
- pN3: Metastasis in a lymph node, more than 5 cm in greatest dimension
- Primary malignant neoplasm of bladder
- Primary spindle cell carcinoma of urinary bladder
- pT1: Tumor invades subepithelial connective tissue
- pT2: Tumor invades muscularis propria
- pT2a: Tumor invades superficial muscle
- pT2b: Tumor invades deep muscle
- pT3: Tumor invades perivesical tissue
- pT3a: Tumor invades perivesical tissue microscopically
- pT3b: Tumor invades perivesical tissue macroscopically
- pT4: Tumor invades any of the following: prostate, uterus, vagina, pelvic wall, abdominal wall
- pT4a: Tumor invades prostate or uterus or vagina
- pT4b: Tumor invades pelvic wall or abdominal wall
- pTa: Non-invasive papillary carcinoma
- Rhabdomyosarcoma of bladder
- Sarcoma of bladder
- Secondary malignant neoplasm of prostate
- Secondary malignant neoplasm of seminal vesicle
- Secondary malignant neoplasm of ureter
- Secondary malignant neoplasm of urethra
- Secondary malignant neoplasm of vagina
- Squamous cell carcinoma of bladder
- T2: Urinary bladder tumor invades muscle
- T2a: Urinary bladder tumor invades superficial muscle
- T2b: Urinary bladder tumor invades deep muscle
- T3: Urinary bladder tumor invades perivesical tissue
- T3a: Bladder tumor invades perivesical tissue microscopically
- T3b: Bladder tumor invades perivesical tissue macroscopically
- T4: Urinary bladder tumor invades any of the following: prostate, uterus, vagina, pelvic wall abdominal wall
- T4a: Bladder tumor invades prostate or uterus or vagina
- T4b: Bladder tumor invades pelvic wall or abdominal wall
- Transitional cell carcinoma of bladder
- Tumor of seminal vesicle
- Tumor of seminal vesicle
Convert to ICD-9 Code
| Source ICD-10 Code | Target ICD-9 Code | |
|---|---|---|
| C67.9 | 188.9 - Malig neo bladder NOS |
Table of Neoplasms
This code is referenced in the table of neoplasms by anatomical site. For each site there are six possible code numbers according to whether the neoplasm in question is malignant, benign, in situ, of uncertain behavior, or of unspecified nature. The description of the neoplasm will often indicate which of the six columns is appropriate.
Where such descriptors are not present, the remainder of the Index should be consulted where guidance is given to the appropriate column for each morphological (histological) variety listed. However, the guidance in the Index can be overridden if one of the descriptors mentioned above is present.
| Neoplasm, neoplastic | Malignant Primary |
Malignant Secondary |
CaInSitu | Benign | Uncertain Behavior |
Unspecified Behavior |
|---|---|---|---|---|---|---|
| »Neoplasm, neoplastic »bladder (urinary) | C67.9 | C79.11 | D09.0 | D30.3 | D41.4 | D49.4 |
| »Neoplasm, neoplastic »bladder (urinary) »orifice | C67.9 | C79.11 | D09.0 | D30.3 | D41.4 | D49.4 |
| »Neoplasm, neoplastic »bladder (urinary) »wall | C67.9 | C79.11 | D09.0 | D30.3 | D41.4 | D49.4 |
Patient Education
Bladder Cancer
The bladder is a hollow organ in your lower abdomen that stores urine. Bladder cancer occurs in the lining of the bladder. It is the sixth most common type of cancer in the United States.
Symptoms include:
- Blood in your urine
- A frequent urge to urinate
- Pain when you urinate
- Low back pain
Risk factors for developing bladder cancer include smoking and exposure to certain chemicals in the workplace. People with a family history of bladder cancer or who are older, white, or male have a higher risk.
Treatments for bladder cancer include surgery, radiation therapy, chemotherapy, and biologic therapy. Biologic therapy boosts your body's own ability to fight cancer.
NIH: National Cancer Institute
[Learn More in MedlinePlus]
Bladder cancer
Bladder cancer is a disease in which certain cells in the bladder become abnormal and multiply uncontrollably to form a tumor. The bladder is a muscular organ in the lower abdomen that stores urine until it can be removed (excreted) from the body.
Bladder cancer may cause blood in the urine, pain during urination, frequent urination, the feeling of needing to urinate without being able to, or lower back pain. Many of these signs and symptoms are nonspecific, which means they may occur in multiple disorders. People who have one or more of these nonspecific health problems often do not have bladder cancer, but have another condition such as an infection.
Bladder cancer develops when tumors form in the tissue that lines the bladder. There are several types of bladder cancer, categorized by the type of cell in the tissue that becomes cancerous. The most common type is transitional cell carcinoma (also known as urothelial carcinoma); others include squamous cell carcinoma and adenocarcinoma. If the tumor spreads (metastasizes) beyond the lining of the bladder into nearby tissues or organs, it is known as invasive bladder cancer.
[Learn More in MedlinePlus]
Bladder Cancer Summary
Learn about bladder cancer risk factors, symptoms, tests to diagnose, factors affecting prognosis, staging, and treatment.[Learn More in MedlinePlus]
Bladder Cancer-Patient Version
Learn about bladder cancer risk factors, symptoms, tests to diagnose, factors affecting prognosis, staging, and treatment.[Learn More in MedlinePlus]
Code History
- FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
- FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
- FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
- FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
- FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
- FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
- FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
- FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016 (First year ICD-10-CM implemented into the HIPAA code set)
